Opko Health, Inc. to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
11/16/2009 10:41:37 AM
More...
|
Opko Health, Inc. Completes Acquisition of NK-1 Compounds from Schering Corporation
11/11/2009 10:25:30 AM
More...
|
Opko Health, Inc. Acquires Lead NK-1 Compounds from Schering-Plough Corporation (SGP)
10/13/2009 8:34:47 AM
More...
|
Opko Health, Inc. Acquires Chilean Pharmaceutical Company, Pharma Genexx S.A. for US $16 Million
10/2/2009 7:42:10 AM
More...
|
Opko Health, Inc. Acquires New Platform Technology
6/17/2009 9:47:48 AM
More...
|
Opko Health, Inc. Invests in Biotechnology Company with Novel Approach to Developing New Drugs
6/15/2009 11:23:06 AM
More...
|
Opko Health, Inc. Invests in Biotechnology Company Sorrento Therapeutics, Inc. Developing Human Antibody Library
6/11/2009 9:46:13 AM
More...
|
Opko Health, Inc. Announces Update on Phase III Clinical Trial of Bevasiranib; Company Decided to Terminate Clinical Study
3/6/2009 9:25:28 AM
More...
|
Opko Health, Inc. To Present Data on Next Generation Anti-Angiogenic VEGF165b-Sparing siRNA at Association for Research in Vision & Ophthalmology (ARVO 2009) Meeting
2/10/2009 12:32:27 PM
More...
|
Opko Health, Inc. Receives FDA 510(k) Clearance for Spectral OCT SLO Combination Imaging System
1/23/2009 7:18:57 AM
More...
|
|